Davide Capodanno/X
Nov 4, 2025, 09:10
OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, posted on X.
“In this post hoc analysis of patients with acute coronary syndromes in the OCCUPI trial, the primary outcome—1-year composite of cardiac death, myocardial infarction, stent thrombosis, or ischemia-driven target vessel revascularisation—occurred in 4.9% of the OCT-guided group versus 9.5% in the angiography-guided group (HR 0.50, 95% CI 0.29–0.87; p=0.011; p=0.273 for interaction). Such benefit was particularly observed in patients who achieved stent optimisation by OCT.”
Read ARTICLE here EDITORIAL here.
Stay updated with Hemostasis Today.
-
Jul 8, 2026, 16:58Emmanuel J Favaloro։ Acquired von Willebrand Syndrome: Key Concepts for Clinical Practice
-
Jul 8, 2026, 16:47Arun V. J: Why Healthcare Professionals Need More Than Medical Training
-
Jul 8, 2026, 16:38Mona Alfaraj: What Does This HbA₂ Pattern Suggest?
-
Jul 8, 2026, 16:34Alexandros Tsourpas: One of CIMB’s Top-Performing Papers of 2025
-
Jul 8, 2026, 16:27Jan Sloves: Medial Thigh Perforators – The Veins We Keep Missing
-
Jul 8, 2026, 16:23William Aird: A Basic Architecture of Hematology
-
Jul 8, 2026, 16:09Abdulrahman Katib: New Leadership for Better VTE Care
-
Jul 8, 2026, 16:09Does MPN Change the Outlook After Splanchnic Vein Thrombosis? – JTH
-
Jul 8, 2026, 16:01Marianne Yee: The Results of RBC Transfusion Survival Studies